Migraine with Aura: Clinical Trials

10 trials for Migraine with Aura, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 2 unknown, 1 recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 5, Terminated 2, Unknown 2, Recruiting 1

Follow Migraine with Aura: new trials by email Literature Review of Migraine with Aura trials Research Report on Migraine with Aura

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Atogepant 60 mg, Propranolol 160 mg, Topiramate 100 mg - Migraine
Phase 4RecruitingMayo Clinic13352025-07-092026-10-19
The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab
Fremanezumab Prefilled Syringe - Migraine Disorders, Migraine With Aura
Phase 4UnknownHospital Clínico Universitario de Valladolid872023-03-012024-02-06
Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine
Almotriptan 12.5 Mg Oral Tablet, Ubrogepant 50Mg Tab - Migraine With Aura, Migraine Without Aura
Phase 4TerminatedMessoud Ashina, MD82022-06-302025-05-31
Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
Diclofenac Potassium 50Mg/Pkt Oral Pwdr, Rimegepant 75 MG - Migraine With Aura, Migraine Without Aura
Phase 4TerminatedDanish Headache Center3002022-05-052025-09-29
Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.
MRI, MRI control, telephone consultation - Migraine Aura
Phase 4CompletedUniversity Hospital, Toulouse602018-12-222021-02-03
Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial
Metoclopramide 10 mg, Placebo, Fentanyl - Migraine Disorders
Phase 4CompletedKocaeli University1482014-12-012017-01-04
Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
Ketorolac Tromethamine, Metoclopramide - Probable Migraine, Migraine With Aura
Phase 4CompletedUniversity of Alberta562012-02-012015-01-26
Preventive Treatment of Episodic and Chronic Migraine
milnacipran - Migraine With Aura, Migraine Without Aura
Phase 4UnknownCalifornia Medical Clinic for Headache452011-04-012011-03-22
Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.
Topiramate - Migraine, Headache
Phase 4CompletedOrtho-McNeil Neurologics, Inc.3852005-09-012011-05-19
Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
topiramate; almotriptan malate - Migraine, Classic Migraine
Phase 4CompletedJanssen-Ortho LLC4062005-06-012011-05-17

Narrower conditions

Migraine without Aura (8)  ·  Migraine Disorders (6)  ·  Emergencies (2)  ·  Agnosia (1)  ·  Brain Diseases (1)  ·  Headache (1)

Broader conditions

Central Nervous System Diseases (10)  ·  Headache Disorders (10)  ·  Headache Disorders, Primary (10)  ·  Nervous System Diseases (10)  ·  Brain Diseases (9)  ·  Migraine Disorders (4)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Disease Attributes (2)  ·  Neurologic Manifestations (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Neurobehavioral Manifestations (1)  ·  Pain (1)  ·  Perceptual Disorders (1)

Interventions

Topiramate (3)  ·  Metoclopramide (2)  ·  almotriptan (2)  ·  Diclofenac (1)  ·  Fentanyl (1)  ·  Ketorolac Tromethamine (1)  ·  Milnacipran (1)  ·  Propranolol (1)  ·  Saline Solution (1)  ·  Tablets (1)  ·  atogepant (1)  ·  rimegepant sulfate (1)  ·  ubrogepant (1)

Sponsors

California Medical Clinic for Headache (1)  ·  Danish Headache Center (1)  ·  Hospital Clínico Universitario de Valladolid (1)  ·  Janssen-Ortho LLC (1)  ·  Kocaeli University (1)  ·  Mayo Clinic (1)  ·  Messoud Ashina, MD (1)  ·  Ortho-McNeil Neurologics, Inc. (1)  ·  University Hospital, Toulouse (1)  ·  University of Alberta (1)

Countries

Denmark (2)  ·  United States (2)  ·  Canada (1)  ·  France (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)

Top investigators

Messoud Ashina, Prof. (2)  ·  Alain Viguier, PH (1)  ·  Angel L Guerrero Peral, MD, PhD (1)  ·  David B Kudrow, MD (1)  ·  Lawrence P. Richer, MD, MSc (1)  ·  Ortho McNeil Neurologics, Inc. Clinical Trial (1)  ·  Todd J Schwedt, M.D. (1)

Results publications

PMID 20974598, PMID 24030685

NIH funding

2017 (1)